Development in children with neurofibromatosis type 1 in early childhood

Franziska Krampe-Heni1, Tamara Fuschlberger2, Ute Wahlländer2

  • 1TUM School of Medicine and Health, Pediatric Neurology, Kölner Platz 1, 80804 Munich, Germany; TUM School of Medicine and Health, Social Pediatrics, Heiglhoftr. 65, 81377 Munich, Germany; German Center for Child and Adolescent Health, partner site Munich, Germany.

Insights

Infants with Neurofibromatosis type 1 (NF1) show global developmental delays, particularly in visuospatial skills. Early intervention is crucial for optimal neurodevelopmental outcomes in children with NF1.

Area of Science:

  • Developmental Pediatrics
  • Neurogenetics
  • Child Psychology

Background:

  • Previous studies on Neurofibromatosis type 1 (NF1) focused on school-aged children.
  • Early childhood development in NF1 remains under-characterized, particularly across all developmental domains.

Purpose of the Study:

  • To characterize the early childhood development of infants with NF1.
  • To identify specific developmental deficits in infants with NF1.

Main Methods:

  • A cross-sectional cohort study of 32 infants with NF1 (12-47 months).
  • Developmental assessment using the Movement Assessment Battery for Children-2 (MFED 1-4).
  • Focused analysis on visual abilities, including color and visuospatial items.

Main Results:

  • Infants with NF1 exhibited global developmental delay.
  • A pronounced delay was observed in applying memorized knowledge.
  • Significant deficits were identified in visuospatial abilities.

Conclusions:

  • This is the first study to examine global development in infants with NF1 under 48 months.
  • Visuospatial deficits in NF1 align with animal model findings and contribute to global delays.
  • Early, targeted developmental therapy is recommended for infants with NF1 to improve neurodevelopmental outcomes.
Abstract